ENLIVEN THERAPEUTICS INC (ELVN) Stock Analyst Ratings
NASDAQ:ELVN - Nasdaq - US29337E1029 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 86% to ELVN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 38.61. This target is 77.13% above the current price.
ELVN was analyzed by 14 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about ELVN.
In the previous month the buy percentage consensus was at a similar level.
ELVN was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-12-13 | BTIG | Initiate | Buy |
| 2024-11-15 | Baird | Maintains | Outperform -> Outperform |
| 2024-10-31 | Jones Trading | Initiate | Buy |
| 2024-10-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-09 | HC Wainwright & Co. | Initiate | Buy |
| 2024-06-11 | Baird | Initiate | Outperform |
| 2024-04-09 | Mizuho | Initiate | Buy |
| 2023-03-29 | Jefferies | Initiate | Buy |
| 2023-03-03 | TD Cowen | Initiate | Outperform |